Table 2 Trend of RSV-related hospitalizations by year and age-classes; OPBG, January 2018– December 2022
2018 N (%) | 2019 N (%) | 2020 N (%) | 2021 N (%) | 2022 N (%) | Total N (%) | P-value* | |
|---|---|---|---|---|---|---|---|
Age classes | |||||||
< 1 | 408 (86.8) | 449 (85.4) | 165 (85.5) | 280 (82.6) | 265 (72.2) | 1,567 (82.7) | < 0.001 |
1–4 | 53 (11.3) | 65 (12.4) | 26 (13.5) | 49 (14.4) | 81 (22.1) | 274 (14.5) | < 0.001 |
5–9 | 6 (1.3) | 10 (1.9) | 2 (1.0) | 7 (2.1) | 13 (3.5) | 38 (2.0) | 0.04 |
≥ 10 | 3 (0.6) | 2 (0.4) | 0 (0.0) | 3 (0.9) | 8 (2.2) | 16 (0.8) | 0.01 |
Total | 470 (100.0) | 526 (100.0) | 193 (100.0) | 339 (100.0) | 367 (100.0) | 1,895 (100.0) |